Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells

European Journal of Cancer

Volumn 35, Issue 10, 1999, Pages 1517-1525

  Wang, I K ^b   Lin Shiau, S Y ^a   Lin, J K ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NONE

Author keywords

Apigenin; Apoptosis; caspase 3; caspase 9; Cytochrome c; Flavonoid; Mitochondrial transmembrane potential; PARP; Reactive oxygen species (ROS)

Indexed keywords

APIGENIN; CASPASE; CYTOCHROME C; FLAVONOID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL;

APIGENIN; APOPTOSIS; CASPASES; CYTOCHROME C GROUP; FLAVONOIDS; HL-60 CELLS; HUMANS; MEMBRANE POTENTIALS; REACTIVE OXYGEN SPECIES;

EID: 0032856994     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00168-9     Document Type: Article

References (35)

1. Dunnick J.K., Hailey J.R. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fund Appl. Toxicol. 19:1992;423-431.
2. Fiala E.S., Reddy B.S., Weisburger J.H. Naturally occurring anticarcinogenic substances in foodstuffs. Ann. Rev. Nutrit. 5:1985;295-321.
3. Hollman P.C., Van Trijp J.M., Buysman M.N.et al. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 418:1997;152-156.
4. Pratt C.B., Relling M.V., Meyer W.H., Douglass E.C., Kellie S.J., Avery L., Phase I. study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors. Am. J. Clin. Oncol. 14:1991;483-486.
5. Huang Y.T., Kuo M.L., Liu J.Y., Huang S.Y., Lin J.K. Inhibitions of protein kinase c and proto-oncogene expressions in NIH 3T3 cells by apigenin. Eur. J. Cancer. 32A:1996;146-151.
6. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
7. McGowan A.J., Fernandes R.S., Verhaegen S., Cotter T.G. Zinc inhibits UV radiation-induced apoptosis but fails to prevent subsequent cell death. Int. J. Radiat. Biol. 66:1994;343-349.
8. Strand S., Hofmann W.J., Hug H.et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumour cells - a mechanism of immune evasion? Nature Med. 2:1996;1361-1366.
9. Enari M., Hase A., Nagata S. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14:1995;5201-5208.
10. Dive C., Hickman J.A. Drug-target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer. 64:1991;192-196.
11. Gunji H., Kharbanda S., Kufe D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. Cancer Res. 51:1991;741-743.
12. Cotter T.G., Glynn J.M., Echeverri F., Green D.R. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12:1992;773-779.
13. Martin S.J., Green D.R. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:1995;349-352.
14. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
15. Takahashi A., Alnemri E.S., Lazebnik Y.A.et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;8395-8400.
16. Faucheu C., Diu A., Chan A.W.et al. A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J. 14:1995;1914-1922.
17. Tewari M., Quan L.T., O'Rourke K.et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
18. Yang J., Liu X., Bhalla K.et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
19. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
20. Hofmann K., Bucher P., Tschopp J., The C.A.R.D. domain: a new apoptotic signaling motif. Trends Biochem. Sci. 22:1997;155-156.
21. Li P., Nijhawan D., Budihardjo I.et al. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
22. Lin Y.L., Juan I.M., Chen Y.L., Liang Y.C., Lin J.K. Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with antiproliferative actions in fibroblast cells. J. Agric. Food Chem. 44:1996;1387-1394.
23. Csokay B., Prajda N., Weber G., Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 60:1997;2157-2163.
24. Lepley D.M., Pelling J.C. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Molec. Carcinogen. 19:1997;74-82.
25. Kang T.B., Liang N.C. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol. 54:1997;1013-1018.
26. Wei Y.Q., Zhao X., Kariya Y., Fukata H., Teshigawara K., Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 54:1994;4952-4957.
27. Plaumann B., Fritsche M., Rimpler H., Brandner G., Hess R.D. Flavonoids activate wild-type p53. Oncogene. 13:1996;1605-1614.
28. Reed J.C. Cytochrome c: can't live with it - can't without it. Cell. 91:1997;559-562.
29. Middleton E Jr, Kandaswami C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In Harborne TH, Liss AR, eds. Flavonoids: Advances in Research Since 1986. New York, Chapman and Hall 1994, 619-625.
30. Ferriola P.C., Cody V., Middleton E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol. 38:1989;1617-1624.
31. Geahlen R.L., Koonchanok N.M., McLaughlin J.L., Pratt D.E. Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds. J. Natl. Products. 52:1989;982-986.
32. Cushman M., Nagarathnam D., Burg D.L., Geahlen R.L. Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J. Med. Chem. 34:1991;798-806.
33. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 53:1997;1649-1657.
34. Jing Y., Waxman S. Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones. Anticancer Res. 15:1995;1147-1152.
35. Shimoi K., Masuda S., Furugori M., Esaki S., Kinae N. Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis. 15:1994;2669-2672.